Related Experiment Video
Updated: Jul 8, 2026

06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment
Clinical & Experimental Ophthalmology
|January 5, 2008
Abstract:
The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established. This case report describes successful treatment of PAM with atypia with a single four day cycle of 0.02% MMC.

